Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Holger Petersen has worked on the following 7 EPO patent applications which have been published in the last five years:

EP14776739

BLISTER TRACK INHALER DEVICE HAVING A SEPARATE END PATH AND METHODS OF USE THEREOF

IPC classification:
A61M 15/00
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14821857

DRUG DELIVERY SYSTEMS

IPC classification:
A61K 9/06, A61K 47/26, A61K 47/36
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14824115

PHARMACEUTICAL COMBINATIONS

IPC classification:
A61K 31/4188, A61K 31/505, A61K 31/519, A61P 35/00
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15199469

NOVEL PHARMACEUTICAL COMPOSITION

IPC classification:
A61K 9/14, A61K 9/54, A61K 31/4152, A61K 47/34, A61P 7/06
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP16183711

METHODS OF ADMINISTRATION OF THROMBOPOIETIN AGONIST COMPOUNDS

IPC classification:
A01N 43/56
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
APPLICATION PUBLISHED
EP15733926

INTERMITTENT DOSING OF MDM2 INHIBITOR

IPC classification:
A61K 31/402, A61K 31/404, A61K 31/4178, A61K 31/4418, A61K 31/4439, A61K 31/47, A61K 31/472, A61K 31/496, A61P 35/00
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15738484

PHARMACEUTICAL DOSAGE FORMS

IPC classification:
A61K 9/20, A61K 31/45
Applicant:
Novartis AG
Agent:
Holger Petersen, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature